BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 27915472)

  • 1. Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease.
    Jhang JF; Kuo HC
    Int Neurourol J; 2016 Nov; 20(Suppl 2):S95-104. PubMed ID: 27915472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesion: A Review and Future Perspectives.
    Akiyama Y
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome.
    Lin HY; Lu JH; Chuang SM; Chueh KS; Juan TJ; Liu YC; Juan YS
    Diagnostics (Basel); 2021 Dec; 12(1):. PubMed ID: 35054241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial Functional Protein and Sensory Receptors in Patients With Interstitial Cystitis/Bladder Pain Syndrome With and Without Hunner's Lesion.
    Jhang JF; Hsu YH; Kuo HC
    Urology; 2016 Dec; 98():44-49. PubMed ID: 27575016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.
    Lee CL; Jiang YH; Kuo HC
    BJU Int; 2013 Dec; 112(8):1156-62. PubMed ID: 23937072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in mast cell infiltration, E-cadherin, and zonula occludens-1 expression between patients with overactive bladder and interstitial cystitis/bladder pain syndrome.
    Liu HT; Shie JH; Chen SH; Wang YS; Kuo HC
    Urology; 2012 Jul; 80(1):225.e13-8. PubMed ID: 22521193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.
    Akiyama Y; Homma Y; Maeda D
    Histol Histopathol; 2019 Jan; 34(1):25-32. PubMed ID: 30015351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome.
    Ueda T; Hanno PM; Saito R; Meijlink JM; Yoshimura N
    Int Neurourol J; 2021 Jun; 25(2):99-110. PubMed ID: 34218637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological characteristics of interstitial cystitis/bladder pain syndrome without Hunner lesion.
    Kim A; Han JY; Ryu CM; Yu HY; Lee S; Kim Y; Jeong SU; Cho YM; Shin DM; Choo MS
    Histopathology; 2017 Sep; 71(3):415-424. PubMed ID: 28394416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adelmidrol + sodium hyaluronate in IC/BPS or conditions associated to chronic urothelial inflammation. A translational study.
    Ostardo E; Impellizzeri D; Cervigni M; Porru D; Sommariva M; Cordaro M; Siracusa R; Fusco R; Gugliandolo E; Crupi R; Schievano C; Inferrera A; Di Paola R; Cuzzocrea S;
    Pharmacol Res; 2018 Aug; 134():16-30. PubMed ID: 29800607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging drugs for interstitial cystitis/bladder pain syndrome (IC/BPS).
    Ogawa T; Ishizuka O; Ueda T; Tyagi P; Chancellor MB; Yoshimura N
    Expert Opin Emerg Drugs; 2015; 20(4):555-70. PubMed ID: 26535808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotyping of interstitial cystitis/bladder pain syndrome.
    Akiyama Y; Hanno P
    Int J Urol; 2019 Jun; 26 Suppl 1():17-19. PubMed ID: 31144756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the Role of Mast Cells in Cystitis-Associated Lower Urinary Tract Dysfunction: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Animal Model Study.
    Wang X; Liu W; O'Donnell M; Lutgendorf S; Bradley C; Schrepf A; Liu L; Kreder K; Luo Y
    PLoS One; 2016; 11(12):e0168772. PubMed ID: 28002455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of Urothelial Inflammation, Apoptosis, and Junction Protein in Patients with Various Bladder Conditions and Storage Bladder Symptoms Suggest Common Pathway Involved in Underlying Pathophysiology.
    Liu HT; Jiang YH; Kuo HC
    Low Urin Tract Symptoms; 2015 May; 7(2):102-7. PubMed ID: 26663690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel research approaches for interstitial cystitis/bladder pain syndrome: thinking beyond the bladder.
    Mullins C; Bavendam T; Kirkali Z; Kusek JW
    Transl Androl Urol; 2015 Oct; 4(5):524-33. PubMed ID: 26813921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions.
    Yu WR; Jiang YH; Jhang JF; Kuo HC
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broaden Horizons: The Advancement of Interstitial Cystitis/Bladder Pain Syndrome.
    Li J; Yi X; Ai J
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36498919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency.
    Ke QS; Jhang JF; Lin TY; Ho HC; Jiang YH; Hsu YH; Kuo HC
    Ci Ji Yi Xue Za Zhi; 2019; 31(3):135-143. PubMed ID: 31258287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of mesenchymal stem cells and exosomes in interstitial cystitis/bladder pain syndrome.
    Wen C; Xie L; Hu C
    J Cell Mol Med; 2022 Feb; 26(3):624-635. PubMed ID: 34953040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.